We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$38.5B
AUM Growth
+$4.48B
(+13%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
2,364
New
149
Increased
1,180
Reduced
895
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$275M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$221M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$193M |
| 4 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$188M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$230M |
| 2 |
Spectrum Brands
SPB
|
+$81.6M |
| 3 |
Chevron
CVX
|
+$79.8M |
| 4 |
Pfizer
PFE
|
+$66.7M |
| 5 |
K
Kellanova
K
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.09% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Technology | 9.81% |
| 4 | Consumer Staples | 7.93% |
| 5 | Communication Services | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HDS
701
DELISTED
HD Supply Holdings, Inc.
HDS
| $11.2M | 0.03% |
317,921
+58,591
| +23% | +$1.95M |
|
|
WIN
702
DELISTED
Windstream Holdings Inc
WIN
| $11.2M | 0.03% |
349,527
+105,653
| +43% | +$5.04M |
|
703
Fulton Financial
FULT
$4.7B
| $11.1M | 0.03% |
852,894
+243,623
| +40% | +$3.09M |
|
704
Motorola Solutions
MSI
$69.4B
| $11.1M | 0.03% |
193,221
-16,274
| -8% | -$974K |
|
705
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
| $11.1M | 0.03% |
230,537
-1,851
| -0.8% | -$93.7K |
|
706
Air Products & Chemicals
APD
$66.3B
| $11.1M | 0.03% |
87,433
-4,998
| -5% | -$682K |
|
707
KeyCorp
KEY
$24.3B
| $11M | 0.03% |
735,215
+264,034
| +56% | +$3.89M |
|
708
HF Sinclair
DINO
$15.9B
| $11M | 0.03% |
258,265
-284,788
| -52% | -$11.5M |
|
709
National Fuel Gas
NFG
$7.84B
| $11M | 0.03% |
186,978
+17,319
| +10% | +$1.09M |
|
710
Lennox International
LII
$18.8B
| $11M | 0.03% |
102,185
+14,501
| +17% | +$1.61M |
|
711
GATX Corp
GATX
$6.55B
| $10.9M | 0.03% |
205,879
+25,143
| +14% | +$1.43M |
|
712
Nabors Industries
NBR
$1.23B
| $10.9M | 0.03% |
15,165
-36,612
| -71% | -$27.6M |
|
713
Synopsys
SNPS
$71.5B
| $10.9M | 0.03% |
215,607
+33,616
| +18% | +$1.64M |
|
714
Avis
CAR
$5.63B
| $10.9M | 0.03% |
247,523
-230,774
| -48% | -$12.2M |
|
715
Ryder
R
$10.3B
| $10.9M | 0.03% |
124,873
-61,300
| -33% | -$5.79M |
|
|
BNY
716
Bank of New York Mellon
BNY
$108B
| $10.9M | 0.03% |
258,774
-34,656
| -12% | -$1.48M |
|
717
Comstock Resources
CRK
$3.97B
| $10.9M | 0.03% |
651,691
+210,075
| +48% | +$4.35M |
|
718
American States Water
AWR
$3.39B
| $10.8M | 0.03% |
289,813
+28,296
| +11% | +$1.09M |
|
|
EGN
719
DELISTED
Energen
EGN
| $10.7M | 0.03% |
156,819
-28,687
| -15% | -$1.99M |
|
720
Teva Pharmaceuticals
TEVA
$35.9B
| $10.7M | 0.03% |
181,038
-7,932
| -4% | -$489K |
|
|
APC
721
DELISTED
Anadarko Petroleum
APC
| $10.7M | 0.03% |
136,997
-1,448
| -1% | -$125K |
|
|
QVCGA
722
DELISTED
QVC Group Inc Series A
QVCGA
| $10.7M | 0.03% |
7,933
+690
| +10% | +$960K |
|
|
BMS
723
DELISTED
Bemis
BMS
| $10.7M | 0.03% |
237,078
-6,368
| -3% | -$291K |
|
|
RDC
724
DELISTED
Rowan Companies Plc
RDC
| $10.7M | 0.03% |
504,569
-216,515
| -30% | -$4.58M |
|
725
Visa
V
$677B
| $10.6M | 0.03% |
158,577
-64,266
| -29% | -$4.36M |
|
Similar funds
DAM
First Trust Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, First Trust Advisors held 2,364 positions worth $38.5B, up 13% from $34B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
First Trust Advisors deployed $4.55B of net new capital in Q2 2015, opening 149 new positions and adding to 1,180 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Chevron, an estimated $79.8M trimmed.
- First Trust Advisors's largest Q2 2015 buy was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q2 2015, an estimated $275M increase.
- First Trust Advisors's biggest Q2 2015 reduction was Chevron, cutting an estimated $79.8M.
- First Trust Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $230M.
- First Trust Advisors's ten largest holdings make up 14% of its $38.5B portfolio in Q2 2015.
- First Trust Advisors opened 149 new positions and closed 134 in Q2 2015.
- First Trust Advisors's portfolio value rose 13% quarter-over-quarter to $38.5B.
Based on First Trust Advisors's 13F filing for Q2 2015, filed 4 Aug 2015.